Oculis and EURETINA Announce Applications Are Now Open for the 2025 Ramin Tadayoni Award

Published on April 24, 2025
ZUG, Switzerland—Oculis Holding AG, a global biopharmaceutical company developing solutions for ophthalmic and neuro-ophthalmic diseases, has announced, in collaboration with the European Society of Retina Specialists (EURETINA), the 2025 Ramin Tadayoni Award.